CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows used in operating activities:
Net loss	$ (29,462)	$ (25,936)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	91	114
Amortization of intangibles	18,485	23,550
Amortization of deferred financing costs	620	605
Accretion expense	1,348	871
Deferred income tax benefit	0	(137)
Stock compensation expense	745	1,469
Fair market value change in derivative liability	354	(6,794)
Fair market value change in contingent consideration	346	(5,502)
(Increase) decrease in operating assets:
Accounts receivable	19,729	9,453
Income tax receivable	734	(121)
Inventory	331	(1,792)
Prepaid expenses and other assets	(720)	1,186
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses	(1,764)	7,453
Accrued allowances	(5,151)	(195)
Interest payable	(4,568)	(5,177)
Other liabilities	(1,918)	(2,366)
Net cash used in operating activities	(800)	(3,319)
Cash flows from investing activities:
Purchase of software and equipment	(3)	(227)
Net cash used in investing activities	(3)	(227)
Cash flows from financing activities:
Payments on Treximet Secured Notes	(12,812)	(14,908)
Net payments on credit facilities	0	(1,000)
Payments on mortgages and capital leases	(23)	(16)
Shares withheld for the payment of taxes	0	(19)
Net cash used in financing activities	(12,835)	(15,943)
Net decrease in cash and cash equivalents	(13,638)	(19,489)
Cash and cash equivalents, beginning of period	36,375	56,135
Cash and cash equivalents, end of period	$ 22,737	$ 36,646